Cargando…
Central nervous system biomarkers for antiobesity drug development()
With antiobesity agents, weight loss can emerge from an array of metabolic, cognitive and behavioural changes that translate into weight change over time. In early drug development, characterising these changes can actually be more informative than simply measuring weight loss. Biomarkers for these...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858811/ https://www.ncbi.nlm.nih.gov/pubmed/23993917 http://dx.doi.org/10.1016/j.drudis.2013.08.015 |